The National Health Service (NHS) England is launching a nationwide program to make optical coherenc...

A recent Chinese study has shed light on the prevalence and influencing factors of ocular pain in in...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...

SpyGlass Pharma, a private biotechnology company specializing in ophthalmology, has announced the co...

The California Institute for Regenerative Medicine (CIRM) has awarded a $6 million, two-year grant t...

Adverum Biotechnologies has released promising 52-week topline results from its Phase 2 LUNA trial a...

Emmecell has announced positive results from its U.S. multicenter Phase 1 trial evaluating EO2002, a...

A team of experts, convened by the National Institutes of Health (NIH), has defined five essential e...

Melt Pharmaceuticals has reported promising topline results from the pivotal Phase 3 trial of MELT-3...

Ocugen has released encouraging preliminary findings from the Phase 1 portion of its Phase 1/2 OCU41...